Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Trading Statement

13 Dec 2013 08:55

RNS Number : 4859V
HaiKe Chemical Group Ltd.
13 December 2013
 

HaiKe Chemical Group Ltd

 

Trading Update

 

HaiKe Chemical Group Limited ("HaiKe" or the "Company" or the "Group") (AIM: HAIK), the AIM quoted petrochemical, speciality chemical and biochemical business based in China, today provides an update on trading ahead of its final results for the twelve month period ended 31 December 2013.

 

The refining business remained volatile throughout H2 with the demand for gasoline recovering in Q3 but then falling in Q4. A contributing factor for this mixed second half was due to the government action regarding environmental concerns about the haze emitted from automobile exhausts. Conversely, the market for diesel picked up slowly in Q4 on the back of rising demand from both industrial and heating use.

 

The relaxation of the pricing mechanism has had an immaterial impact on the refineries, and overall the move towards a freer operating environment remains encouraging. The Company has adapted operating strategies in order to compensate for the volume shortfall and improve overall margins, for example making continued improvement to the product mix in order to focus on the more profitable high-end products, through the development of niche products for specific areas and by increasing trading activity which has low but stable margins.

 

The speciality chemicals business remained profitable in H2. Specifically, High-tech Spring has overcome the difficulties of volume decrease and margin squeeze and made a modest profit in H2. Hebang generated a small profit in Q4 but this was not sufficient to cover the prior losses. The Group has taken certain actions to adapt to the changing environment and further develop the speciality chemical division. These include making best use of its existing resources by, for example, increasing exposure to trading and implementing more efficient tax planning.

 

There was no significant change to the biochemicals business which made comparative earnings in H2.

 

On the financial side, the Group recorded a total turnover of CNY36.8 billion for the first 11 months of 2013, up 140% year-on-year. Accumulated net loss after tax for the period was CNY359.8 million, compared to a loss of CNY186.9 million for the same period in 2012. Net borrowings (short/long term borrowing minus bank deposit) amounted CNY7.4 billion at end-Nov, compared to CNY6.2 billion at beginning of the year.

 

Against this background the Group continues to explore its restructuring options in order to try to realise value for all stakeholders. 

 

Mr Xiaohong Yang, Executive Chairman, said:

 

"We are disappointed by the performance especially in the refinery division. Given the difficult operating environment, we've carried out several measures to compensate for the shortfall in the refinery as well as further development of speciality chemicals. Meanwhile, the Company continues to examine various options for the best interest of our shareholders."

 

For further information please contact:

 

HaiKe Chemical Group

George Zeng, Chief Financial Officer

george@haikechemical.com

+86 138 2520 2570

Westhouse Securities

Martin Davison

 

+44 (0) 20 7601 6100

Cardew Group

Shan Shan Willenbrock

Tom Horsman

haike@cardewgroup.com 

+44 (0) 20 7930 0777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMMMZRFGGFZG
Date   Source Headline
28th May 20127:00 amRNSNotice of AGM and Posting of Annual Report
4th May 20127:00 amRNSFinal Results
23rd Apr 20127:00 amRNSNotice of Results
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
23rd Jan 20123:13 pmRNSDirector/PDMR Shareholding
18th Jan 20123:48 pmRNSDirector/PDMR Shareholding
11th Jan 20127:00 amRNSTrading Statement
5th Dec 201112:19 pmRNSDirector's Disclosure
15th Nov 20117:00 amRNSHaiKe increases stake in key refinery
27th Sep 20117:00 amRNSHalf Yearly Report
28th Jul 20117:00 amRNSContract with National Retailer
25th Jul 20117:00 amRNSBuyout of minority interests in key subsidiary
22nd Jul 20117:00 amRNSTrading Statement
6th Jul 20112:06 pmRNSHolding(s) in Company
22nd Jun 20119:46 amRNSResult of AGM
6th Jun 20117:00 amRNSBuyout of minority in a key subsidiary
20th May 20113:28 pmRNSNotice of AGM and Posting of Annual Report
19th May 20117:00 amRNSFinal Results
3rd May 20117:00 amRNSAppointment of Executive Director
2nd Feb 201112:51 pmRNSNew Share Option Plan
20th Jan 201111:53 amRNSTrading Update and Appointment of CFO
24th Nov 20107:00 amRNSTrading Statement
23rd Sep 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSHalf Yearly Report
17th Sep 201012:52 pmRNSHolding(s) in Company
10th Aug 20101:44 pmRNSHolding(s) in Company
30th Jul 20101:46 pmRNSDirectorate Change
27th Jul 20109:07 amRNSResults of AGM and EGM
12th Jul 20106:16 pmRNSNotice of EGM
29th Jun 201012:14 pmRNSAnnual Financial Report & Notice of AGM
24th Jun 20107:00 amRNSFinal Results
6th Apr 20109:19 amRNSRuilin refinery facility
12th Mar 201010:55 amRNSWebsite launch and change of office address
12th Feb 201012:04 pmRNSDirectorate Change
25th Jan 20107:00 amRNSTrading Statement
15th Jan 20107:00 amRNSDirectorate Change
18th Dec 200912:44 pmRNSNomad's name change
19th Nov 200912:00 pmRNSTrading Statement
28th Oct 20094:41 pmRNSHolding(s) in Company
22nd Oct 20096:11 pmRNSHolding(s) in Company
24th Sep 20097:00 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNotice of Results
24th Jul 200911:02 amRNSResult of AGM
23rd Jul 20097:00 amRNSTrading Statement
1st Jul 20099:39 amRNSDirector Appointment
30th Jun 20097:00 amRNSNotice of AGM and Posting of Annual Report
11th Jun 200910:34 amRNSDirector/PDMR Shareholding
10th Jun 200912:24 pmRNSDirector/PDMR Shareholding
9th Jun 20097:00 amRNSFinal Results
8th Jun 20093:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.